Literature DB >> 26914059

Introducing folding stability into the score function for computational design of RNA-binding peptides boosts the probability of success.

Xingqing Xiao1, Paul F Agris2, Carol K Hall1.   

Abstract

A computational strategy that integrates our peptide search algorithm with atomistic molecular dynamics simulation was used to design rational peptide drugs that recognize and bind to the anticodon stem and loop domain (ASL(Lys3)) of human tRNAUUULys3 for the purpose of interrupting HIV replication. The score function of the search algorithm was improved by adding a peptide stability term weighted by an adjustable factor λ to the peptide binding free energy. The five best peptide sequences associated with five different values of λ were determined using the search algorithm and then input in atomistic simulations to examine the stability of the peptides' folded conformations and their ability to bind to ASL(Lys3). Simulation results demonstrated that setting an intermediate value of λ achieves a good balance between optimizing the peptide's binding ability and stabilizing its folded conformation during the sequence evolution process, and hence leads to optimal binding to the target ASL(Lys3). Thus, addition of a peptide stability term significantly improves the success rate for our peptide design search.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  atomistic molecular dynamics simulation; binding affinity and specificity; peptide design; search algorithm; tRNALys3UUU

Mesh:

Substances:

Year:  2016        PMID: 26914059     DOI: 10.1002/prot.25021

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  2 in total

1.  Simulation study of the ability of a computationally-designed peptide to recognize target tRNALys3 and other decoy tRNAs.

Authors:  Xingqing Xiao; Binwu Zhao; Paul F Agris; Carol K Hall
Journal:  Protein Sci       Date:  2016-10-07       Impact factor: 6.725

2.  De novo design of peptides that coassemble into β sheet-based nanofibrils.

Authors:  Xingqing Xiao; Yiming Wang; Dillon T Seroski; Kong M Wong; Renjie Liu; Anant K Paravastu; Gregory A Hudalla; Carol K Hall
Journal:  Sci Adv       Date:  2021-09-03       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.